Abstract
Background: Glypican-3 (GPC3) is a newly identified target molecule for the early diagnosis of hepatocellular carcinoma (HCC), while targeted inhibiti......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
